Skip to main content

Peer Review reports

From: Impact of chronic obstructive pulmonary disease on the efficacy and safety of neoadjuvant immune checkpoint inhibitors combined with chemotherapy for resectable non-small cell lung cancer: a retrospective cohort study

Original Submission
4 Nov 2023 Submitted Original manuscript
1 Dec 2023 Reviewed Reviewer Report
10 Dec 2023 Reviewed Reviewer Report
10 Dec 2023 Reviewed Reviewer Report - Dongli Yu
21 Dec 2023 Author responded Author comments - Weigang Dong
22 Dec 2023 Author responded Author comments - Weigang Dong
Resubmission - Version 2
21 Dec 2023 Submitted Manuscript version 2
27 Dec 2023 Reviewed Reviewer Report
28 Dec 2023 Reviewed Reviewer Report - Dongli Yu
3 Jan 2024 Reviewed Reviewer Report
5 Jan 2024 Author responded Author comments - Weigang Dong
Resubmission - Version 3
5 Jan 2024 Submitted Manuscript version 3
8 Jan 2024 Reviewed Reviewer Report
12 Jan 2024 Author responded Author comments - Weigang Dong
Resubmission - Version 4
12 Jan 2024 Submitted Manuscript version 4
Publishing
20 Jan 2024 Editorially accepted
30 Jan 2024 Article published 10.1186/s12885-024-11902-w

You can find further information about peer review here.

Back to article page